描述 |
PD 123319是血管紧张素II受体拮抗剂,IC50为34 nM。 |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
相关类别 |
|
||||||||||||
靶点 |
IC50: 34 nM (AT2 Receptor)[1]
|
||||||||||||
体外研究 |
PD 123319显示出在许多不同组织中区分AII受体的两个亚类。 125I-AII在牛肾上腺肾小球细胞的膜制剂中特异性标记AII的两类结合位点。第一类(DuP-753敏感)代表AII总结合位点的约85%,并且对DuP-753具有高亲和力(IC50为92.9nM)。 PD-123319对125I-AII与该位点的结合没有任何影响。第二类结合位点对PD-123319更敏感,IC50为6.9 nM,对DuP-753的亲和力低得多(IC50约为10 microM)[2]。 |
||||||||||||
溶解度 |
体外:
在DMSO中10mM
|
||||||||||||
储备液 |
|
||||||||||||
动物实验 |
在16 SHR中研究了CBF自动调节的下限。 8只动物接受PD 123319,而8只作为对照。静脉内施用PD123319或盐水,并且在注射后和开始自动调节研究之前使BP稳定10分钟。随后通过将血液抽入注射器诱导出血性低血压。通过这种方式,BP逐步降低到可获得的最低水平。在整个研究中,CBF的测量间隔为10至15 mmHg。 |
||||||||||||
存储 |
请将产品存放在分析证书中的建议条件下。
|
||||||||||||
运输 |
室温;可能会有所不同 |
||||||||||||
SMILES |
O=C([C@@H]1CC2=C(N=CN2CC3=CC=C(N(C)C)C(C)=C3)CN1C(C(C4=CC=CC=C4)C5=CC=CC=C5)=O)O |
||||||||||||
参考文献 |
|
||||||||||||
相关活性 小分子 |
人血管紧张素II | AVE 0991 | A 779 | 曲尼司特 | PD 123319 二(三氟乙酸盐) | 替米沙坦 | CGP-42112 | LCZ696 | 奥洛立更 | 非马沙坦 | 茴三硫 | Sparsentan | C型利钠肽(CNP)(1-22),人 |
密度 | 1.2±0.1 g/cm3 |
---|---|
沸点 | 775.8±60.0 °C at 760 mmHg |
分子式 | C31H32N4O3 |
分子量 | 508.61 |
闪点 | 423.0±32.9 °C |
PSA | 78.67000 |
LogP | 4.40 |
外观性状 | powder |
蒸汽压 | 0.0±2.8 mmHg at 25°C |
折射率 | 1.641 |
储存条件 | 2-8°C |
水溶解性 | H2O: 12?mg/mL |
1H-Imidazo[4,5-c]pyridine-6-carboxylic acid, 1-[[4-(dimethylamino)-3-methylphenyl]methyl]-5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-, (6S)- |
(S)-1-<<4-(dimethylamino)-3-methylphenyl>methyl>-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo<4,5-c>pyridine-6-carboxylic acid |
(6S)-1-[4-(Dimethylamino)-3-methylbenzyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid trifluoroacetate (1:2) |
(6S)-1-[4-(Dimethylamino)-3-methylbenzyl]-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridine-6-carboxylic acid |
1H-Imidazo[4,5-c]pyridine-6-carboxylic acid, 1-[[4-(dimethylamino)-3-methylphenyl]methyl]-5-(2,2-diphenylacetyl)-4,5,6,7-tetrahydro-, (6S)-, compd. with 2,2,2-trifluoroacetic acid (1:2) |
(3S)-9-[(4-DIMETHYLAMINO-3-METHYL-PHENYL)METHYL]-4-(2,2-DIPHENYLACETYL)-4,7,9-TRIAZABICYCLO[4.3.0]NONA-7,10-DIENE-3-CARBOXYLIC ACID |
1-((4-(Dimethylamino)-3-methylphenyl)methyl)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazo[4.5-c]pyridine-6-carboxyli |
PD 123,319 |
PD 123,319 DITRIFLUOROACETATE |
pd 123,319 di(trifluoroacetate) salt |
1H-Imidazo(4,5-c)pyridine-6-carboxylic acid, 1-((4-(dimethylamino)-3-methylphenyl)methyl)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-, (S)- |
S-(+)-1-((4-(dimethylamino)-3-methylphenyl)methyl)-5-(diphenylacetyl)-4,5,6,7-tetrahydro-1H-imidazol(4,5-c)pyridine-6-carboxylic acid |
PD 123319 |